LIMINATUS PHARMA INC. (LIMNW): Institutional Ownership
Hedge funds and institutional managers reporting a position in LIMNW. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
2
13F filers
Aggregate Value
$16K
Across holders
Last Price
$0.04
2026-06-26
Sector
GICS
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. CIK 0001510281 | Hedge Fund | 234K | $11K | 69.6% | 0.0% | Unchanged | +$0 | Q1 2026 |
| MOORE CAPITAL MANAGEMENT, LP CIK 0001448574 | Hedge Fund | 125K | $5K | 30.4% | 0.0% | Unchanged | +$0 | Q1 2026 |